疫週刊由台灣醫療衛生專業人才主持，提供最新全球新冠肺炎疫情訊息，強化醫療人員與民眾之間的溝通管道，透過對話將醫學常識普及化，促進彼此合作提升衛生交流，展現台灣共同體的專業與人道。
［疫週刊｜看國際］每週日 9:30 a.m at clubhouse 📍全球疫情現況週報
疫週刊 | 看國際
Claim This Podcastby 疫週刊
5.0(5 reviews)
96 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇹🇼
Podcast Overview
疫週刊由台灣醫療衛生專業人才主持，提供最新全球新冠肺炎疫情訊息，強化醫療人員與民眾之間的溝通管道，透過對話將醫學常識普及化，促進彼此合作提升衛生交流，展現台灣共同體的專業與人道。 ［疫週刊｜看國際］每週日 9:30 a.m at clubhouse 📍全球疫情現況週報
Language
🇨🇳
Publishing Since
5/29/2021
1 verified contact email on file for 疫週刊 | 看國際
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
March 12, 2023
【🦠疫週刊|看國際】Ep.90 台灣政策鬆綁/長新冠成本/醫療科技政策/資料科學與經濟
<p>今天來聊聊政策鬆綁！</p> <p>更有精彩內容：</p> <p>1. 長新冠成本隱藏，二十七萬誰來扛</p> <p>(NBC News 專題)</p> <p>轉換入 SBCA 研討會：</p> <p>2. 等我五十歲那天，科技政策已改變</p> <p>(諾貝爾獎得主演講)</p> <p>3. 統計生命年工具，應當調整到永續</p> <p>(加拿大 16 年未調整過)</p> <p>4. 疫情風險疑過曝，接種事件啟示錄</p> <p>(額外的風險增加與人民的願付價格不一致，社會成本卻已產生)</p> <p>5. 兒童演算有疑慮，智庫提出新數據</p> <p>(研究指出兒童政策上的數字要做 1.2-3.0 倍加權，現階段提案 2 倍)</p> <p>6. 效益效用與利益，待改善成本分析</p> <p>(美國很多研究人員已經看到相關工具的模糊地帶可以差上百倍，外加須參照 CEA Second Panel 研究，故台灣可以從中學習)</p> <p>進入藥價議題：</p> <p>7. 藥事經濟研究上，促成健康安全網</p> <p>(淺談美國藥價居高不下的要素，以及線性疊加成本演算的缺點)</p> <p>進入 Newsweek 評分：</p> <p>8. 醫院評分怎麼比，各院自有一體系</p> <p>(描述 Joint Committee 評比，以及台灣要躋身世界前百的挑戰)</p> <p>9. 為提升品質努力，資料科學與經濟</p> <p>(美國引入非醫療專業人士進入醫院支援管理的主因)</p> <p>結論部分：</p> <p>10. 成本效益要研究，疫情過後換一手</p> <p>(目前台灣欠缺如 ICER-NICE 等機構可能無法讓政策與時俱進的隱患)</p> <p><br></p> <p>———————————</p> <p>加入Clubhouse 社群</p> <p>「疫週刊。國際疫情資訊社群」連結加入社群！</p> <p>———————————</p> <p>加入LINE 社群</p> <p>https://reurl.cc/VDajAn</p> <p>———————————</p> <p>【疫週刊｜看國際】每週日 9:30 a.m at clubhouse</p> <p>全球疫情現況週報</p> <p>若你覺得我們節目不錯，請記得訂閱喔！</p> <p>也歡迎到clubhouse上直接跟我們一起聊聊！</p> <p>————————————</p> <p>主談：姜冠宇、Lawrence、劉筱茜（Sarah）、PacKitty</p>
February 15, 2023
【🦠疫週刊|看國際】EP89. 口罩鬆綁/防疫免費時代結束/更新歐洲全開放政策
<p>開放政策陸續在各國實施了</p> <p>卻也不是回到從前</p> <p>來聽聽『拐點』是怎麼回事</p> <p>還有歐洲英國法國的具體措施整理喔</p> <p>———————————</p> <p>加入Clubhouse 社群</p> <p>「疫週刊。國際疫情資訊社群」連結加入社群！</p> <p>———————————</p> <p>加入LINE 社群</p> <p>https://reurl.cc/VDajAn</p> <p>———————————</p> <p>【疫週刊｜看國際】每週日 9:30 a.m at clubhouse</p> <p>全球疫情現況週報</p> <p>若你覺得我們節目不錯，請記得訂閱喔！</p> <p>也歡迎到clubhouse上直接跟我們一起聊聊！</p> <p>————————————</p> <p>主談：姜冠宇、Lawrence、PacKitty</p>
January 29, 2023
【🦠疫週刊|看國際】Ep.88 春節後措施觀察/兒童重複感染風險/美收回AZ口服藥授權/英撤接種站
<p>春節後疫情似有回升？正常現象。</p> <p>本週除了分析措施降級的可能</p> <p>也帶來一些對於兒童免疫的提醒</p> <p>AZ口服藥被FDA撤回</p> <p>英國撤大型疫苗接種站</p> <p>一切似乎正在走向後疫情</p> <p>我們還會看見哪些發展？</p>
96 total episodes available
Deep-dive analytics for 疫週刊 | 看國際
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is 疫週刊 | 看國際?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.